Search

Since its inception at MSK 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New York City and beyond.

… Monday, April 26, 2021 Since its inception at Memorial Sloan Kettering Cancer Center 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New

Dr. Diane Reidy-Lagunes discusses cannabis and cancer with MSK’s Director of Pediatric Integrated Medicine, Dr. Nirupa Raghunathan, and cancer survivor and winner of TV’s “Survivor: Africa”, Ethan Zohn.

… Wednesday, May 4, 2022 Cannabis is an ancient plant that has been used for rituals and medicine for 5,000 years. People with cancer have turned to cannabis — better known as weed or marijuana — to relieve effects of both the illness and the treatment. Because of its ever-changing legal status, studies

MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees.

… Thursday, February 10, 2022 MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees. MSK was featured on previous Forbes’ Best Employers lists but this

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

… Wednesday, October 9, 2013 Summary Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries. This image shows a cross section of a piece of tissue that was surgically

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomes 21 students to the Summer Undergraduate Research Program.

… Friday, May 26, 2017 The 2017 Summer Undergraduate Research Program (SURP) began with the arrival of 21 undergraduate students, under the auspices of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s SURP class includes 13 women and eight men, all of whom are undergraduates

Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.

… Friday, January 10, 2025 Adrienne Boire, MD, PhD , has been a knitter almost her entire life. In the famously frigid plains of Minnesota, where Dr. Boire grew up, knitting is taught as part of regular elementary education. It’s a way to make math fun for kids, teach concentration skills, and let them

MSK investigators have shown that a gene mutation linked to many kinds of cancer can also cause birth defects of the nervous system.

… Friday, February 26, 2016 Summary MSK investigators have shown that a mutation in a gene called PTEN that’s linked to many kinds of cancer can also cause birth defects of the nervous system. Their research unveils the mechanism by which the mutation affects cell shape and prevents cells from properly

Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in Health Affairs on February 6, 2017, and to speak with the study author, contact [email protected].

… Tuesday, February 7, 2017 Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis.  Job loss can have devastating financial consequences, including increased risk

As flu season ramps up amid the continuing uncertainty of the COVID-19 pandemic, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the risks and what precautions they could take to safeguard against the flu.

… Monday, November 16, 2020 As flu season ramps up amid the continuing uncertainty of the COVID-19 pandemic, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the risks and what precautions they could take to safeguard against the flu this year. The

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.

… Friday, May 24, 2013 Summary Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering. Since the completion of the Human Genome Project in 2003, many researchers